A clinical trial on vitiligo
Phase 2
- Conditions
- Health Condition 1: null- hypopigmented patches on the body
- Registration Number
- CTRI/2018/02/012071
- Lead Sponsor
- ational institute of siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age: Between 5 to 12 years
Sex: Both male and female children
Hypo pigmented patches with hyper pigmented border without any structural changes in any part of the body
Willing to co operate for taking photographs whenever required with hisher consent
Exclusion Criteria
1.Albinism
2.Thyroid disorder
3.Leprosy
4.HIV
5.Fungal infestation
6.Burns
Patient with lesion in the lips ,sole , palm and genitalia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of the hypopigmented lesions in the affected areaTimepoint: 45 days after medications
- Secondary Outcome Measures
Name Time Method Reduction in the recurrence rate of the lesions.Timepoint: after 48 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Mayiliragaadhi chooranam's efficacy in vitiligo treatment?
How does the combination of Mayiliragaadhi chooranam and Kandangkathiri ennai compare to monotherapy in vitiligo clinical outcomes?
Are there specific biomarkers that correlate with response to Siddha-based treatments for Venpadai (vitiligo)?
What are the potential adverse events associated with Mayiliragaadhi chooranam and Kandangkathiri ennai in vitiligo patients?
What is the current evidence for Siddha formulations like Mayiliragaadhi chooranam in vitiligo compared to conventional therapies such as corticosteroids or JAK inhibitors?